Cardiac Remodeling Following Percutaneous Mitral Valve Repair - Initial Results Assessed by Cardiovascular Magnetic Resonance Imaging
Standard
Cardiac Remodeling Following Percutaneous Mitral Valve Repair - Initial Results Assessed by Cardiovascular Magnetic Resonance Imaging. / Radunski, U K; Franzen, O; Barmeyer, A; Lange, M; Lund, G; Rudolph, V; Schlüter, M; Adam, G; Reichenspurner, H; Blankenberg, S; Baldus, S; Müllerleile, Kai.
in: ROFO-FORTSCHR RONTG, Jahrgang 186, Nr. 10, 2014, S. 951-958.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cardiac Remodeling Following Percutaneous Mitral Valve Repair - Initial Results Assessed by Cardiovascular Magnetic Resonance Imaging
AU - Radunski, U K
AU - Franzen, O
AU - Barmeyer, A
AU - Lange, M
AU - Lund, G
AU - Rudolph, V
AU - Schlüter, M
AU - Adam, G
AU - Reichenspurner, H
AU - Blankenberg, S
AU - Baldus, S
AU - Müllerleile, Kai
N1 - © Georg Thieme Verlag KG Stuttgart · New York.
PY - 2014
Y1 - 2014
N2 - Purpose: Percutaneous mitral valve repair with the MitraClip device (Abbott Vascular, Redwood City, California, USA) is a novel therapeutic option in patients with mitral regurgitation. This study evaluated the feasibility of cardiac volume measurements by cardiovascular magnetic resonance imaging (CMR) to assess reverse myocardial remodeling in patients after MitraClip implantation. Materials and Methods: 12 patients underwent CMR at baseline (BL) before and at 6 months follow-up (FU) after MitraClip implantation. Cine-CMR was performed in short- and long-axes for the assessment of left ventricular (LV), right ventricular (RV) and left atrial (LA) volumes. Results: Assessment of endocardial contours was not compromised by the device-related artifact. No significant differences in observer variances were observed for LV, RV and LA volume measurements between BL and FU. LV end-diastolic (median 127 [IQR 96 - 150] vs. 112 [86 - 150] ml/m2; p = 0.03) and LV end-systolic (82 [54 - 91] vs. 69 [48 - 99] ml/m2; p = 0.03) volume indices decreased significantly from BL to FU. No significant differences were found for RV end-diastolic (94 [75 - 103] vs. 99 [77 - 123] ml/m2; p = 0.91), RV end-systolic (48 [42 - 80] vs. 51 [40 - 81] ml/m2; p = 0.48), and LA (87 [55 - 124] vs. 92 [48 - 137] ml/m2; p = 0.20) volume indices between BL and FU. Conclusion: CMR enables the assessment of cardiac volumes in patients after MitraClip implantation. Our CMR findings indicate that percutaneous mitral valve repair results in reverse LV but not in RV or LA remodeling. Key points: • Volume measurements by cardiovascular magnetic resonance imaging are feasible following percutaneous mitral valve repair despite device-related artifacts.• A significant reduction of left ventricular volume was found in terms of beneficial, reverse left ventricular remodeling after 6-month follow-up.• No significant reduction was found in right ventricular or left atrial volumes after percutaneous mitral valve repair after 6-month follow-up. Citation Format: • Radunski UK, Franzen O, Barmeyer A et al. Cardiac Remodeling Following Percutaneous Mitral Valve Repair - Initial Results Assessed by Cardiovascular Magnetic Resonance Imaging. Fortschr Röntgenstr 2014; DOI: 10.1055/s-0034-1366216.
AB - Purpose: Percutaneous mitral valve repair with the MitraClip device (Abbott Vascular, Redwood City, California, USA) is a novel therapeutic option in patients with mitral regurgitation. This study evaluated the feasibility of cardiac volume measurements by cardiovascular magnetic resonance imaging (CMR) to assess reverse myocardial remodeling in patients after MitraClip implantation. Materials and Methods: 12 patients underwent CMR at baseline (BL) before and at 6 months follow-up (FU) after MitraClip implantation. Cine-CMR was performed in short- and long-axes for the assessment of left ventricular (LV), right ventricular (RV) and left atrial (LA) volumes. Results: Assessment of endocardial contours was not compromised by the device-related artifact. No significant differences in observer variances were observed for LV, RV and LA volume measurements between BL and FU. LV end-diastolic (median 127 [IQR 96 - 150] vs. 112 [86 - 150] ml/m2; p = 0.03) and LV end-systolic (82 [54 - 91] vs. 69 [48 - 99] ml/m2; p = 0.03) volume indices decreased significantly from BL to FU. No significant differences were found for RV end-diastolic (94 [75 - 103] vs. 99 [77 - 123] ml/m2; p = 0.91), RV end-systolic (48 [42 - 80] vs. 51 [40 - 81] ml/m2; p = 0.48), and LA (87 [55 - 124] vs. 92 [48 - 137] ml/m2; p = 0.20) volume indices between BL and FU. Conclusion: CMR enables the assessment of cardiac volumes in patients after MitraClip implantation. Our CMR findings indicate that percutaneous mitral valve repair results in reverse LV but not in RV or LA remodeling. Key points: • Volume measurements by cardiovascular magnetic resonance imaging are feasible following percutaneous mitral valve repair despite device-related artifacts.• A significant reduction of left ventricular volume was found in terms of beneficial, reverse left ventricular remodeling after 6-month follow-up.• No significant reduction was found in right ventricular or left atrial volumes after percutaneous mitral valve repair after 6-month follow-up. Citation Format: • Radunski UK, Franzen O, Barmeyer A et al. Cardiac Remodeling Following Percutaneous Mitral Valve Repair - Initial Results Assessed by Cardiovascular Magnetic Resonance Imaging. Fortschr Röntgenstr 2014; DOI: 10.1055/s-0034-1366216.
U2 - 10.1055/s-0034-1366216
DO - 10.1055/s-0034-1366216
M3 - SCORING: Journal article
C2 - 24648233
VL - 186
SP - 951
EP - 958
JO - ROFO-FORTSCHR RONTG
JF - ROFO-FORTSCHR RONTG
SN - 1438-9029
IS - 10
ER -